Displaying 1 - 3 of 3
| Active Ingredient | OESTRADIOL |
| Therapeutic Class | ESTROGENS |
| Indications | HRT (may be cyclical and progestogen should be added for 10-14 days of the cycle or may be continuously combined). Prevention of post-menopausal osteoporosis and vascular disease. Atrophic va More ... |
| Caution | Less thromboembolic disease than semisyntheticor synthetic oestrogen, spotting, breast tenderness, chloasma, weight changes. C.f. prescribing in liver disease p. 16. |
| Dose Range |
Oral: 0.5-2mg daily . Vaginal: 2-4g (0.2-0.4mg oestradiol) daily for 1-2 weeks, then increase to 1-2g/day for 1-2 weeks; then maintainance dose of 1g 1-3 times weekly for 3 weeks, then off for 1 week; then rep eat cy cle once vaginal muco |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | OESTRADIOL | CYPROTERONE |
| Therapeutic Class | COMBINED PREPARATIONS FOR MENOPAUSAL SYMPTOMS |
| Indications | Symptoms due to oestrogenic deficiency ,and for the prophylaxis of postmenopausal osteoporosis in women at risk of developing fractures. |
| Caution |
Headache, dizziness, nausea, changes in bleeding patterns. Do not chew tablets, swallow whole. |
| Dose Range | 1 tablet daily. |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | OESTRADIOL | NORGESTREL |
| Therapeutic Class | COMBINED PREPARATIONS FOR MENOPAUSAL SYMPTOMS |
| Indications | Symptoms due to oestrogenic deficiency ,and for the prophylaxis of postmenopausal osteoporosis in women at risk of developing fractures. |
| Caution |
Headache, dizziness, nausea, changes in bleeding patterns. Do not chew tablets, swallow whole. |
| Dose Range | 1 tablet daily. |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |